Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study

Author:

Hutajulu Susanna HildaORCID,Howdon Daniel,Taroeno-Hariadi Kartika Widayati,Hardianti Mardiah Suci,Purwanto Ibnu,Indrasari Sagung Rai,Herdini Camelia,Hariwiyanto Bambang,Ghozali Ahmad,Kusumo Henry,Dhamiyati Wigati,Dwidanarti Sri Retna,Tan I. Bing,Kurnianda Johan,Allsop Matthew JohnORCID

Abstract

Purpose This study aimed to determine the survival outcome and prognostic factors of patients with nasopharyngeal cancer accessing treatment in Yogyakarta, Indonesia. Methods Data on 759 patients with NPC diagnosed from 2007 to 2016 at Dr Sardjito General Hospital were included. Potential prognostic variables included sociodemographic, clinicopathology and treatment parameters. Multivariable analyses were implemented using semi-parametric Cox proportional hazards modelling and fully parametric survival analysis. Results The median time of observation was 14.39 months. In the whole cohort the median observed survival was 31.08 months. In the univariable analysis, age, education status, insurance type, BMI, ECOG index, stage and treatment strategy had an impact on overall survival (OS) (p values <0.01). Semi-parametric multivariable analyses with stage stratification showed that education status, ECOG index, and treatment modality were independent prognostic factors for OS (p values <0.05). In the fully parametric models age, education status, ECOG index, stage, and treatment modality were independent prognostic factors for OS (p values <0.05). For both multivariable analyses, all treatment strategies were associated with a reduced hazard (semi-parametric models, p values <0.05) and a better OS (parametric models, p values <0.05) compared with no treatment. Furthermore, compared with radiation alone or chemotherapy alone, a combination of chemotherapy and radiation either in a form of concurrent chemoradiotherapy (CCRT), sequential chemotherapy and radiation, or induction chemotherapy followed by CCRT demonstrated a reduced hazard (hazard ratio/HR 0.226, 95% confidence interval/CI 0.089–0.363, and HR 0.390, 95%CI 0.260–0.519) and a better OS (time ratio/TR 3.108, 95%CI 1.274–4.942 and TR 2.531, 95%CI 1.829–3.233) (p values < 0.01). Conclusions Median OS for the cohort was low compared to those reported in both endemic and non-endemic regions. By combining the findings of multivariable analyses, we showed that age, education status, ECOG index, stage and first treatment modality were independent predictors for the OS.

Funder

KWF Kankerbestrijding

The Indonesian Society for Hematology and Medical Oncology Yogyakarta Branch

Universitas Gadjah Mada’s Publisher and Publication Board

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

1. The enigmatic epidemiology of nasopharyngeal carcinoma;ET Chang;Cancer Epidemiol Biomarkers Prev,2006

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin,2018

3. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004–2008;V Chee Ee Phua;Asian Pacific Journal of Cancer Prevention: APJCP,2013

4. Nasopharyngeal carcinoma;MLK Chua;The Lancet,2016

5. High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island;BC Devi;Cancer Epidemiol Biomarkers Prev,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3